These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9804058)

  • 1. Protective effect of talipexole on MPTP-treated planarian, a unique parkinsonian worm model.
    Kitamura Y; Kakimura J; Taniguchi T
    Jpn J Pharmacol; 1998 Sep; 78(1):23-9. PubMed ID: 9804058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.
    Kitamura Y; Kohno Y; Nakazawa M; Nomura Y
    Jpn J Pharmacol; 1997 May; 74(1):51-7. PubMed ID: 9195297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiparkinsonian activity of talipexole in MPTP-treated monkeys: in combination with L-dopa and as chronic treatment.
    Irifune M; Nomoto M; Fukuda T
    Eur J Pharmacol; 1994 Oct; 264(2):117-23. PubMed ID: 7851473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of talipexole on motor behavior in normal and MPTP-treated common marmosets.
    Irifune M; Nomoto M; Fukuda T
    Eur J Pharmacol; 1993 Jul; 238(2-3):235-40. PubMed ID: 8104807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys.
    Domino EF; Ni L; Zhang H; Kohno Y; Sasa M
    Eur J Pharmacol; 1997 May; 325(2-3):137-44. PubMed ID: 9163560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of antiparkinsonian drugs and caspase inhibitors in a parkinsonian flatworm model.
    Kitamura Y; Inden M; Sanada H; Takata K; Taniguchi T; Shimohama S; Orii H; Mochii M; Agata K; Watanabe K
    J Pharmacol Sci; 2003 Jun; 92(2):137-42. PubMed ID: 12832841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of talipexole on contraversive rotation and functional impairment in MPTP-induced chronic hemiparkinsonian monkeys.
    Domino EF; Ni L; Zhang H; Kohno Y; Sasa M
    Jpn J Pharmacol; 1998 Jul; 77(3):227-33. PubMed ID: 9717770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tremor activity of talipexole produced by selective dopamine D2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum.
    Kohno Y; Fukuzaki K; Kitahara K; Koja T
    Eur J Pharmacol; 1997 Jan; 319(2-3):197-205. PubMed ID: 9042591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dopaminergic neuroprotection and reconstruction of neural network tiara].
    Kitamura Y
    Yakugaku Zasshi; 2010 Oct; 130(10):1263-72. PubMed ID: 20930477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
    Schmidt N; Ferger B
    Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apomorphine as a neuroprotective drug: a study in MPTP-treated mice and potential relevance to ischemia.
    Orzi F; Castri P; Fornai F
    Funct Neurol; 2001; 16(4 Suppl):153-8. PubMed ID: 11996511
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey.
    Bezard E; Brefel C; Tison F; Peyro-Saint-Paul H; Ladure P; Rascol O; Gross CE
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Oct; 23(7):1237-46. PubMed ID: 10581645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958.
    Grondin R; Goulet M; Morissette M; Bédard PJ; Di Paolo T
    Eur J Pharmacol; 1999 Aug; 378(3):259-63. PubMed ID: 10493101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroprotective effect of talipexole from paraquat-induced cell death in dopaminergic neuronal cells.
    Gómez-Sánchez R; Bravo-San Pedro JM; Niso-Santano M; Soler G; Fuentes JM; González-Polo RA
    Neurotoxicology; 2010 Dec; 31(6):701-8. PubMed ID: 20673835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment.
    Petroske E; Meredith GE; Callen S; Totterdell S; Lau YS
    Neuroscience; 2001; 106(3):589-601. PubMed ID: 11591459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of talipexole on emesis-related changes in abdominal afferent vagal activity and ileal serotonin metabolism in rats.
    Minami M; Nemoto M; Endo T; Hamaue N; Kohno Y
    Res Commun Mol Pathol Pharmacol; 1997 Jan; 95(1):67-82. PubMed ID: 9055350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
    Joyce JN; Woolsey C; Ryoo H; Borwege S; Hagner D
    BMC Biol; 2004 Oct; 2():22. PubMed ID: 15473914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
    Morissette M; Grondin R; Goulet M; Bédard PJ; Di Paolo T
    J Neurochem; 1999 Feb; 72(2):682-92. PubMed ID: 9930741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole.
    Joyce JN; Presgraves S; Renish L; Borwege S; Osredkar T; Hagner D; Replogle M; PazSoldan M; Millan MJ
    Exp Neurol; 2003 Nov; 184(1):393-407. PubMed ID: 14637109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
    Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y
    Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.